“This draft standard outlines the performance testing methods for implantable neurostimulators with closed-loop functionality, specifically using brain-computer interface (BCI) technology. The guidelines address critical aspects of testing these advanced medical devices, focusing on ensuring their safety and efficacy.
With the rapid development of neuroscience and biomedical engineering, closed-loop implantable neuromodulation technology is advancing rapidly. This document emphasizes the need for standardized testing methods to keep pace with these technological innovations, ensuring alignment with international standards. Doing so will not only improve regulatory efficiency but also help reduce regulatory costs and difficulties.
Key components of the draft include test plans, methods for analyzing baseline and follow-up EEG data, stress tests, and the specific requirements for closed-loop neurostimulators. The document also provides guidelines for data handling, algorithm testing, signal detection, and noise immunity.
Neurostimulator testing involves several stages, such as perceptual performance assessments under different environmental conditions, quality control of datasets, and error statistics to monitor algorithm performance. Additionally, it defines parameters for stimulation thresholds, abnormal signal identification, and safety protocols.
The last date for public comment on this draft is August 30, 2024, encouraging industry feedback to refine the standards further.”
Region:China
Reach out to us and let’s unravel your Regulatory puzzle together. Unlock regulatory solutions with our global subject matter experts and tap into a wealth of regulatory intelligence.
Speak to an Expert